Interaction of Iron Homeostasis and Fatty Acid Metabolism in the Development of Glucose Intolerance in Women with Previous Gestational Diabetes Mellitus.
gestational diabetes mellitus
glucose tolerance
insulin resistance
iron
serum fatty acids
transferrin receptor
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
20 Jul 2023
20 Jul 2023
Historique:
received:
20
06
2023
revised:
14
07
2023
accepted:
18
07
2023
medline:
31
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
A gestational diabetes mellitus (GDM) diagnosis during pregnancy means an increased risk of developing type 2 diabetes later in life. By following up with women after GDM we aimed to examine the relationship between iron parameters, individual fatty acids (FAs) and desaturases in the development of impaired glucose metabolism (IGM). Based on an oral glucose tolerance test (OGTT), six years after GDM, 157 women were grouped as having normal glucose tolerance (NGT) or IGM. Fasting serum FAs, activity of desaturases and iron parameters (ferritin, transferrin, iron, soluble transferrin receptor, total iron binding capacity, hepcidin) were measured, and clinical and anthropometric measurements taken. Soluble transferrin receptor was higher in the IGM group compared to the NGT group (3.87 vs. 3.29 mg/L,
Identifiants
pubmed: 37513632
pii: nu15143214
doi: 10.3390/nu15143214
pmc: PMC10385184
pii:
doi:
Substances chimiques
Blood Glucose
0
Iron
E1UOL152H7
Fatty Acids
0
Transferrins
0
Fatty Acid Desaturases
EC 1.14.19.-
Immunoglobulin M
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Stiftelsen Erik and Lily Philipsons Minnesfond
ID : No grant number.
Organisme : Emil and Wera Cornell Foundation
ID : No grant number.
Organisme : Tore Nilson Foundation
ID : No grant number.
Organisme : Swedish state under the ALF agreement between the Swedish government and the country councils
ID : ALFGBG-720851
Références
N Engl J Med. 2008 May 8;358(19):1991-2002
pubmed: 18463375
Int J Obes (Lond). 2009 Jul;33(7):768-74
pubmed: 19488049
J Clin Endocrinol Metab. 2021 Oct 21;106(11):e4641-e4651
pubmed: 34147035
Mol Metab. 2019 Jul;25:1-10
pubmed: 31113756
Nutrition. 2012 Jun;28(6):691-7
pubmed: 22365910
Nutrients. 2018 Nov 02;10(11):
pubmed: 30400149
Biochem Biophys Res Commun. 2002 Dec 20;299(5):853-6
pubmed: 12470657
FASEB J. 2019 Feb;33(2):1771-1786
pubmed: 30207798
J Matern Fetal Neonatal Med. 2019 Jul;32(13):2166-2172
pubmed: 29325459
Annu Rev Nutr. 2016 Jul 17;36:241-73
pubmed: 27146016
Nutr Diabetes. 2020 Jun 8;10(1):17
pubmed: 32513913
Am J Clin Nutr. 2007 Jul;86(1):189-97
pubmed: 17616780
Ann N Y Acad Sci. 2011 Dec;1243:47-53
pubmed: 22211892
Cell Metab. 2021 Aug 3;33(8):1624-1639.e9
pubmed: 34174197
Diabetes Care. 2014 Jan;37 Suppl 1:S81-90
pubmed: 24357215
Diabetes Obes Metab. 2009 May;11(5):472-9
pubmed: 19207293
Nutrition. 2018 Jan;45:49-58
pubmed: 29129237
J Diabetes Res. 2018 Jun 05;2018:4207067
pubmed: 29967793
Exp Hematol. 2001 Jun;29(6):677-85
pubmed: 11378262
Biochem Soc Trans. 2008 Oct;36(Pt 5):905-8
pubmed: 18793159
Diabetologia. 2012 Oct;55(10):2613-2621
pubmed: 22752055
BMJ. 2020 May 13;369:m1361
pubmed: 32404325
PLoS One. 2015 Feb 03;10(2):e0116855
pubmed: 25647178
J Nutr Biochem. 2022 Aug;106:109013
pubmed: 35447320
Cell Metab. 2013 Mar 5;17(3):329-41
pubmed: 23473030
Curr Dev Nutr. 2017 Nov 15;2(1):1-8
pubmed: 29955721
Eur J Clin Invest. 2017 Mar;47(3):221-230
pubmed: 28075490
Diabet Med. 2004 Feb;21(2):103-13
pubmed: 14984444
BMC Pregnancy Childbirth. 2023 May 8;23(1):326
pubmed: 37158870
J Diabetes Res. 2021 Jun 28;2021:9999612
pubmed: 34258295
Ann N Y Acad Sci. 2002 Jun;967:183-95
pubmed: 12079847